Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080819 · ClinicalTrials.gov registry record · Phase 2
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT02080819: Completed Phase 2 study, sponsored by Virginia Commonwealth University.
NCT02080819 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 131 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02080819, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
This project proposes to investigate the role of brain connectivity in the mechanism of treatment response to dopaminergic medications in cocaine dependence.
Primary Outcome
Treatment effectiveness score based on number of positive urine drug screens
Interventions
- DRUG levodopa/carbidopa 400/100 BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-01-21 |
| Phase | Phase 2 |
What the finished NCT02080819 record still lists
NCT02080819 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which levodopa/carbidopa 400/100 BID is the first listed.
NCT02080819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02080819 about?
NCT02080819 is a clinical study titled "Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse". This project proposes to investigate the role of brain connectivity in the mechanism of treatment response to dopaminergic medications in cocaine dependence.
What is the current status of trial NCT02080819?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2014-02. Estimated completion is 2017-01-21.
What interventions are being tested in trial NCT02080819?
The interventions under investigation include: levodopa/carbidopa 400/100 BID (DRUG).
Who is sponsoring clinical trial NCT02080819?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02080819's enrollment target sits among peer trials
131 541st of 2000 higher than 1,458 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia